Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Blue Sky MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Blue Sky MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 138 · Grade C

Blue Sky MD

Visit Blue Sky MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Blue Sky MD a bad call — it's best for north carolina patients who want clinic-based follow-up or a mix of office visits and telehealth with regular coaching. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
77
Transparency
90
88
Access Breadth
93
56
Clinical Oversight
92
91
Track Record
88
78
CoreAge RxBrief Score 94 · 71Blue Sky MD

Price, coverage & the tracker

CoreAge RxBlue Sky MD
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm medication + program total

Semaglutide advertised from $40/week in-office; required weight-loss program charges are not included in a complete quote.

Full price details

Complete medication-and-program quote unknown; semaglutide advertised $40/week in-office with required program enrollment; earlier listing: From $160/mo (starting dose, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm medication + program total

Tirzepatide advertised from $60/week in-office; required weight-loss program charges are not included in a complete quote.

Full price details

Complete medication-and-program quote unknown; tirzepatide advertised $60/week in-office with required program enrollment; earlier listing: From $240/mo (starting dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeNorth Carolina clinics and statewide telehealth; confirm service and medication availability for your location
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Blue Sky MD: In-office medication offers start at $40/week semaglutide and $60/week tirzepatide, with required program enrollment. The complete program charge remains unknown.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.